HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Brooks, A. D. Articles by Derus, C. L. Search for Related Content PubMed PubMed Citation Articles by Brooks, A. D. Articles by Derus, C. L.

AMIE D. BROOKS, PHARM.D., BCPS, CDE, is Associate Professor of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, MO; when this article was written, she was Assistant Professor of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL. RAMI S. RIHANI, PHARM.D., is Director of Pharmacy; and CHARLES L. DERUS, M.D., M.B.A., is Medical Director, Dreyer Medical Clinic, Aurora, IL.

Address correspondence to Dr. Brooks at the Division of Pharmacy Practice, St. Louis College of Pharmacy, 4588 Parkview Place, St. Louis, MO 63110 (abrooks{at}stlcop.edu).

Purpose. An evaluation of the effectiveness of a program at achieving improved glycemic control, lipid levels, and adherence to preventive care measures in diabetes mellitus patients was conducted. Summary. An interdisciplinary diabetes health management program (DHMP) was implemented, which included physicians, clinical pharmacists, registered nurses, and registered dieticians. The patients are seen by a clinical pharmacist with the option of individual or group visits with other members of the multidisciplinary team. Clinical pharmacist interventions include education and comprehensive medication management through collaborative practice agreements held with physicians. The collaborative agreements allow the clinical pharmacist to initiate, adjust, or discontinue pharmacotherapy and order pertinent laboratory tests and podiatry referrals that are within the scope of the medication management protocol. A retrospective review was conducted of the 707 patients enrolled in the program between April 2002 and April 2004. The mean ± S.D. number of days between baseline and follow-up values was 140 ± 62. Eighty-four percent of the enrolled patients were diagnosed with type 2 diabetes mellitus, 69% met the National Cholesterol Education Program’s criteria for metabolic syndrome, and 51% were male. The mean glycosylated hemoglobin (HbA1c) value dropped significantly, and the percentage of patients who were at or below the American Diabetes Association’s established HbA1c goal of 7% increased significantly. Lipid values for enrolled patients increased 25% from baseline. Adherence to preventive care measures (e.g., annual eye and foot examinations) also significantly improved from baseline to follow-up. Conclusion. Involvement of pharmacists in an interdisciplinary DHMP has improved patient care. Index terms: Ambulatory care; Clinical pharmacists; Diabetes mellitus; Disease management; Interventions; Patient care; Patient information